CO07204-Phase I/II of Oxaliplatin, Capecitabine & Sorafenib for Advanced Pancreatic & Biliary Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Sorafenib
Related studies linked through entity extraction aliases.
Phase I/II Trial of Letrozole and Sorafenib in Post-Menopausal Hormone-Receptor + Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase II Study of Bevacizumab + Sorafenib in Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)
- Status
- WITHDRAWN
- Phase
- PHASE1
Combined Treatment of Sorafenib and Pegylated Interferon α2b in Stage IV Metastatic Melanoma
- Status
- COMPLETED
- Phase
- PHASE2
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
- Status
- TERMINATED
- Phase
- NA
TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Radiation With Sorafenib in Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib
- Status
- COMPLETED
- Phase
- PHASE2
MRI Study of BAY 43-9006 in Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250
- Status
- COMPLETED
- Phase
- NA
Sorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE2
PEG-Interferon Alfa-2b and Sorafenib in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
- Status
- TERMINATED
- Phase
- PHASE2
Sorafenib and Bevacizumab in Combination With Paclitaxel in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib and Radiotherapy in the Treatment of Invasive Bladder Cancer With Conservative Intent
- Status
- COMPLETED
- Phase
- PHASE1
Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer
- Status
- COMPLETED
- Phase
- NA